PFF

Pulmonary Fibrosis Care Expands To 74 Medical Centers In U.S.

Retrieved on: 
Wednesday, August 10, 2022
Quality, Respiratory disease, MSN, Hospital, Medical college, NP, ILD, Cystic Fibrosis Foundation, PF, RN, Research, Caregiver, PFF, Radiology, Patient, CCN, Rush University Medical Center, Interstitial lung disease, Doctor of Philosophy, Pulmonary fibrosis, Pathology, Rheumatology, University, Pulmonology, Medicine

CHICAGO, Aug. 10, 2022 /PRNewswire/ -- Americans living with pulmonary fibrosis, a life-threatening lung disease, have gained access to specialized care through the Pulmonary Fibrosis Foundation's (PFF) Care Center Network (CCN).

Key Points: 
  • CHICAGO, Aug. 10, 2022 /PRNewswire/ -- Americans living with pulmonary fibrosis, a life-threatening lung disease, have gained access to specialized care through the Pulmonary Fibrosis Foundation's (PFF) Care Center Network (CCN).
  • The Pulmonary Fibrosis Foundation (PFF) has announced that six new sites have joined the CCN to help diagnose, treat, and provide support for the more than 250,000 Americans living with pulmonary fibrosis (PF).
  • "Our new PFF Care Center Network sites offer much-needed comprehensive care for patients living with PF and interstitial lung disease (ILD).
  • The 74 sites now operating in the PFF Care Center Network are:

Bintai Kinden JV Wins Contracts to Supply O&G-Related Equipment

Retrieved on: 
Thursday, July 28, 2022
Petro, Knowledge, Industry, Partnership, PFF, Bursa, Contract, M&E, KBK, O&G, Hydraulic machinery

Bintai Kinden, through wholly-owned subsidiary Kejuruteraan Bintai Kindenko Sdn Bhd (KBK), has a 51% interest in Bintai Energy, with the other 49% interest held by PFF.

Key Points: 
  • Bintai Kinden, through wholly-owned subsidiary Kejuruteraan Bintai Kindenko Sdn Bhd (KBK), has a 51% interest in Bintai Energy, with the other 49% interest held by PFF.
  • KBK is a M&E engineering services specialist while PFF is a supplier of pipes, flanges, fittings, valves and other O&G-related equipment.
  • Bintai Energy has been awarded with similar contracts since its establishment in March 2022 and we hope to be able to win more such contracts given our expertise and knowledge."
  • With the most recent sub-contracts, Bintai Energy has clinched a total of approximately RM9.0 million under the Bintai Energy JV since its formation.

ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Driving Parkinson's Disease Pathology

Retrieved on: 
Wednesday, July 27, 2022
Goal, Inflammation, University, View, Phenotype, Multiple sclerosis, Kidney, Awareness, Center, Neurosurgery, Paralysis, ASC, Physiology, Traumatic brain injury, Twitter, Foundation, The Michael J. Fox Foundation, Parkinson's disease, Research, Government, FSGS, PFF, Associate, CNS, NIH Intramural Research Program, Therapy, Focal segmental glomerulosclerosis, Multimedia, DRS, Volunteering, Clinical trial, Fox Trial Finder, Ageing, Inflammasome, Cognitive neuroscience, Kidney disease, Miami, Patient, LinkedIn, Department, Stroke, Faculty, Microbiology, Alport syndrome, Invention, MJFF, Miami Project to Cure Paralysis, Pharmaceutical industry, Medicine, Immunology, Biophysics, Facebook

WESTON, Fla., July 27, 2022 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa), a clinical-stage specialty biopharmaceutical company developing first-in-class drugs for treatment of inflammatory and renal diseases, is honored to receive a grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to determine if IC 100 inhibition of inflammasomes and ASC specks blocks microglial-mediated inflammation in a PD model. The research will be conducted at the University of Miami Miller School of Medicine in the labs of IC 100 inventors, Drs. Robert W. Keane and Juan Pablo de Rivero Vaccari. Dr. Keane is Professor, Departments of Physiology and Biophysics, Neurological Surgery and Microbiology, Immunology, and The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine. Dr. de Rivero Vaccari is an Associate Professor in the Department of Neurological Surgery and The Miami Project to Cure Paralysis, and a Distinguished Faculty Member of the Center for Cognitive Neuroscience and Aging at the University of Miami Miller School of Medicine.

Key Points: 
  • Fox Foundation for Parkinson's Research (MJFF) to determine if IC 100 inhibition of inflammasomes and ASC specks blocks microglial-mediated inflammation in a PD model.
  • The research will be conducted at the University of Miami Miller School of Medicine in the labs of IC 100 inventors, Drs.
  • Dr. Keane is Professor, Departments of Physiology and Biophysics, Neurological Surgery and Microbiology, Immunology, and The Miami Project to Cure Paralysis at the University of Miami Miller School of Medicine.
  • Fox Foundation is dedicated to accelerating a cure for Parkinson's disease and improved therapies for those living with the condition today.

Pulmonary Fibrosis Foundation Introduces Community Registry for Self-Reported Data

Retrieved on: 
Monday, July 18, 2022
Research, Transplant, Lung, Disease, Atmosphere, Patient, Registry, Database, Hospital, Organic, Interstitial lung disease, Inflammation, Foundation, BBB, Charity Navigator, Technology, MBA, Risk, Pulmonary fibrosis, National Health Council, Cystic Fibrosis Foundation, Survival, Caregiver, Probability, Rockcastle Regional Hospital and Respiratory Care Center, Better Business Bureau, MS, Sex, Boehringer Ingelheim, Speller, PFF, Scar, Health, Hoffmann-La Roche, Community, Anticoagulant, Disorder, Awareness, United Therapeutics, Medical device, ILD, Genentech, MD

CHICAGO, July 18, 2022 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) has launched the PFF Community Registry, a distinct data set of the PFF Registry™ that will collect participant-reported data provided directly by patients with pulmonary fibrosis (PF) and interstitial lung disease (ILD), their caregivers and family members, and lung transplant recipients previously diagnosed with PF or ILD.

Key Points: 
  • CHICAGO, July 18, 2022 /PRNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) has launched the PFF Community Registry, a distinct data set of the PFF Registry that will collect participant-reported data provided directly by patients with pulmonary fibrosis (PF) and interstitial lung disease (ILD), their caregivers and family members, and lung transplant recipients previously diagnosed with PF or ILD.
  • Pulmonary fibrosis means scarring of the lung and can be seen in many types of ILD.
  • The PFF Community Registry will complement the PFF Patient Registry, established in 2016 to track medical data from more than 2,000 PF patients across PFF Care Centers nationwide.
  • The Pulmonary Fibrosis Foundation mobilizes people and resources to provide access to high quality care and leads research for a cure so people with pulmonary fibrosis will live longer, healthier lives.

PFF Walk Celebrates Hope and Community for People Affected by Pulmonary Fibrosis

Retrieved on: 
Tuesday, July 12, 2022
Liberty State Park, Registry, Disease, Charity Navigator, Walkers, Prevalence, Pulmonary fibrosis, Education, Awareness, Better Business Bureau, National Health Council, Foundation, PF, Patient, CEO, PFF, City, Liberty, Walking, Degenerative disease, Research, Cystic Fibrosis Foundation, BBB, Caregiver, Interstitial lung disease, Pharmaceutical industry, Engineered wood, Medicine

CHICAGO, July 12, 2022 /PRNewswire/ -- The Pulmonary Fibrosis Foundation's (PFF) sixth annual PFF Walk returns in person and virtually from July through October 2022 to raise funds and awareness to support people living with pulmonary fibrosis (PF).

Key Points: 
  • CHICAGO, July 12, 2022 /PRNewswire/ -- The Pulmonary Fibrosis Foundation's (PFF) sixth annual PFF Walk returns in person and virtually from July through October 2022 to raise funds and awareness to support people living with pulmonary fibrosis (PF).
  • "We have a community of champions who have remained strong through the pandemic while battling this serious lung disease," said William T. Schmidt, PFF President and CEO.
  • The new PFF Community Registry , launching in July, will be featured at a tent at the Walk sites.
  • The mission of the Pulmonary Fibrosis Foundation is to accelerate the development of new treatments and ultimately a cure for pulmonary fibrosis.

Ethos Asset Management Inc., USA Announces Sustainability and Net Zero Bonus to Clients Reducing Interest Rates and Confirms 49 million USD Awarded Under Philanthropic Financing Facility in 2021

Retrieved on: 
Thursday, July 7, 2022
Ethos, 2016 United Nations Climate Change Conference, United Nations, Social responsibility, Philanthropy, Paris Agreement, Kyoto Protocol, Carbon, Climate, United Nations Framework Convention on Climate Change, Foundation, Growth, Climate change, PFF, Goal, Global Financing Facility, Organic, Culture, Automation, SAN, ZERO, Carbon accounting, Paris, University, Social Problems, CSS, Organization, Corporate social responsibility, Temperature, Time, Government, Biodiversity, NET, UNFCCC, Renewable energy, Recycling, Agriculture, Bank

Sustainability cannot be established without changing the paradigms of production and the pricing of common properties, both leading to an increase of production costs.

Key Points: 
  • Sustainability cannot be established without changing the paradigms of production and the pricing of common properties, both leading to an increase of production costs.
  • Being aware of its responsibility Ethos Asset Management pledges to contribute to tackle the challenges by promoting projects committed to NET ZERO EMISSIONS PRODUCTION.
  • Within its Financing Facilities, Ethos will grant a 0.5% reduction to interest rates for project financing applications presenting accountability concepts safeguarding the NET ZERO EMISSION target and overall sustainability.
  • Furthermore, ETHOS will preferentially approve financing for projects openly and accountably being committed to sustainable rules of conduct.

I Am Athlete Inks Content Deal with SiriusXM

Retrieved on: 
Monday, April 25, 2022
Newton, NFL, News, Athlete, PFF, WNBA, NASDAQ, IAA, Human, Atmosphere, SVP, Love, Company, LeSean, National Election Pool, Sirius XM, Rookie, Radio, List of Sirius XM Radio channels, Sport, Partnership, House, NBA, SIRI, Toy, Entertainment, HOA

NEW YORK, April 25, 2022 /PRNewswire/ -- SiriusXM and I Am Athlete, the athlete-led media network founded by former NFL All-Pro receiver Brandon Marshall, announced today they have joined forces in a new expansive content deal that includes a live nightly radio show and other game-changing projects.

Key Points: 
  • I Am Athlete and SiriusXM will produce a new nightly show that will air nationwide on SiriusXM's Mad Dog Sports Radio (channel 82 on SiriusXM radios and on the SXM App).
  • I Am Athlete Tonight episodes will also be available as podcasts after they air on SiriusXM.
  • SiriusXM is an extraordinary company that shares our passion for innovation in storytelling and giving the athlete a platform," said Marshall.
  • And together, we look forward to developing new talent and content for I Am Athlete and SiriusXM that will appeal to listeners everywhere."

Telly Leung, Arielle Jacobs and Derrick Davis Join All-Star Line-Up For Pulmonary Fibrosis Foundation Benefit

Retrieved on: 
Monday, April 18, 2022
Country music, CEO, Carousel, Pulmonary fibrosis, A Pop Song Saved My Life, PFF, BBB, Divinity, National Health Council, Life, Charity Navigator, COVID-19, Phantom, The Lion King, Research, Good, Interstitial lung disease, Caregiver, Degenerative disease, Program, Better Business Bureau, Patient, Broadway Cares/Equity Fights AIDS, Edison Theatre, Inflammation, Lung, The Good Fight, Blood, City, Isabel, For Once in My Life (Tony Bennett album), Foundation, Sex, Confession, Come, PF, Film, Scar, Academy, Prevalence, Health, Academy of Country Music, Lillias White, Nightclub, Medicine, Cagney

has become one of Broadway's hottest tickets for both in-person and virtual attendees," said Julie Halston, winner of the 2020 Isabelle Stevenson Tony Award.

Key Points: 
  • has become one of Broadway's hottest tickets for both in-person and virtual attendees," said Julie Halston, winner of the 2020 Isabelle Stevenson Tony Award.
  • "Our celebrity talent is proud to help the PFF drive research and support patients living with this devastating lung disease."
  • The pulmonary fibrosis community is grateful for the opportunity to honor his generosity and support of the PFF.
  • The mission of the Pulmonary Fibrosis Foundation is to accelerate the development of new treatments and ultimately a cure for pulmonary fibrosis.

ArrowMark Financial Corp. Reports Fourth Quarter 2021 Results

Retrieved on: 
Monday, February 28, 2022
GLOBE, Risk, Chief executive officer, Income, Webcast, Net asset value, PFF, Investment, Security (finance), IShares S&P Global 100, Annual report, Industry, Company, Sale, LLC, U.S. Securities and Exchange Commission, Review, Q&A, Nasdaq, Eastern Time Zone, CEO, SEC, Holding company, Financial adviser

DENVER, Feb. 28, 2022 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp. (Nasdaq: BANX) (ArrowMark Financial or the Company), an investment company registered with the Securities and Exchange Commission (SEC), today announced results for the fourth fiscal quarter ended December 31, 2021.

Key Points: 
  • DENVER, Feb. 28, 2022 (GLOBE NEWSWIRE) -- ArrowMark Financial Corp. (Nasdaq: BANX) (ArrowMark Financial or the Company), an investment company registered with the Securities and Exchange Commission (SEC), today announced results for the fourth fiscal quarter ended December 31, 2021.
  • Fourth Quarter 2021 Investment Highlights:
    A complete listing of investments as of the end of the quarter can be found on the Companys website at ir.arrowmarkfinancialcorp.com, under SEC filings.
  • The Net Asset Value at the end of the quarter reflected the Companys regular fourth quarter cash dividend and special cash dividend.
  • ArrowMark Financial is an SEC registered non-diversified, closed-end management investment company listed on the NASDAQ Global Select Market under the symbol "BANX."

Global Idiopathic Pulmonary Fibrosis (IPF) Markets, 2017-2030 - Insights on Esbriet, Ofev, Tipelukast, Pamrevlumab, KD025, PRM 151, GKT831, and Other IPF Therapies - ResearchAndMarkets.com

Retrieved on: 
Thursday, February 24, 2022
Biotechnology, Pharmaceutical, Health, Boehringer Ingelheim, ILD, Population, Degenerative disease, Genentech, Type–token distinction, Growth, Scheidler v. National Organization for Women (2006), IPF, PFF, Prevalence, Investment, Organization, Fibrosis, COVID-19, Vicki Belo, NICE, Advantage, SWOT, Nintedanib, Interstitial lung disease, Competitive landscape, Adult, Research report, USD, Idiopathic pulmonary fibrosis, Safety, FDA, U.S. FDA, Phenotype, Lung cancer, Patient, R, National Institute for Health and Care Excellence, Technology, CAGR, Association, National Institute, Aluminium, Renewable energy, Pharmaceutical industry, Retail, Fine chemical, Pirfenidone

Based on region, the Global Idiopathic Pulmonary Fibrosis (IPF) market is divided into the U.S., EU5, and Japan.

Key Points: 
  • Based on region, the Global Idiopathic Pulmonary Fibrosis (IPF) market is divided into the U.S., EU5, and Japan.
  • What are the inhibiting factors and impact of COVID-19 on the Global Idiopathic Pulmonary Fibrosis (IPF) Market during the assessment period?
  • Which are the products/segments/applications/areas to invest in over the assessment period in the Global Idiopathic Pulmonary Fibrosis (IPF) Market?
  • What modes and strategic moves are considered favorable for entering the Global Idiopathic Pulmonary Fibrosis (IPF) Market?